{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:08:17Z","timestamp":1788469697083,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ecl.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T16:32:18Z","timestamp":1678984338000},"page":"417-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence"],"prefix":"10.1016","volume":"52","author":[{"given":"Carolyn","family":"Vespoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Mohamed Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nasser Kabbany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadakkal","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ecl.2023.02.001_bib1","doi-asserted-by":"crossref","first-page":"e042843","DOI":"10.1136\/bmjopen-2020-042843","article-title":"Increasing prevalence of NAFLD\/NASH among children, adolescents and young adults from 1990 to 2017: A population-based observational study","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ecl.2023.02.001_bib2","unstructured":"Obesity and overweight. World Health Organization. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed January 28, 2023."},{"key":"10.1016\/j.ecl.2023.02.001_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.923744","article-title":"Disparities in the Prevalence of Childhood Obesity-Related Comorbidities: A Systematic Review","volume":"10","author":"Obita","year":"2022","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.ecl.2023.02.001_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/apt.17165","article-title":"Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analyses","volume":"56","author":"Yi","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.ecl.2023.02.001_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ecl.2023.02.001_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.184","article-title":"Perspectives on youth-onset nonalcoholic fatty liver disease","volume":"3","author":"Castillo-Leon","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"10.1016\/j.ecl.2023.02.001_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ecl.2023.02.001_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the Burden of Chronic Liver Disease among Hospitalized US Adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"27","key":"10.1016\/j.ecl.2023.02.001_bib9","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ecl.2023.02.001_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2009","journal-title":"QJM"},{"issue":"11","key":"10.1016\/j.ecl.2023.02.001_bib11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4254\/wjh.v7.i11.1439","article-title":"Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics","volume":"7","author":"Marzuillo","year":"2015","journal-title":"World J Hepatol"},{"issue":"41","key":"10.1016\/j.ecl.2023.02.001_bib12","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3748\/wjg.v19.i41.6969","article-title":"PNPLA3 I148M polymorphism and progressive liver disease","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ecl.2023.02.001_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17474124.2019.1595589","article-title":"Pediatric NAFLD: an overview and recent developments in diagnostics and treatment","volume":"13","author":"Draijer","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ecl.2023.02.001_bib14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/hep.23832","article-title":"A\u00a0common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents","volume":"52","author":"Santoro","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.ecl.2023.02.001_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: new genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ecl.2023.02.001_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MPG.0000000000000463","article-title":"Novel association between a nonsynonymous variant (R270H) of the G-protein-coupled receptor 120 and liver injury in children and adolescents with obesity","volume":"59","author":"Marzuillo","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.ecl.2023.02.001_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ecl.2023.02.001_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cld.1008","article-title":"Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic Workup","volume":"17","author":"Phen","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"11","key":"10.1016\/j.ecl.2023.02.001_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112806","article-title":"Bile acid receptors and the gut\u2013liver axis in nonalcoholic fatty liver disease","volume":"10","author":"Xue","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ecl.2023.02.001_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/hep.23133","article-title":"Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study","volume":"50","author":"Carter-Kent","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ecl.2023.02.001_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.20842","article-title":"Histopathology of pediatric nonalcoholic fatty liver disease","volume":"42","author":"Schwimmer","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ecl.2023.02.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1627456","article-title":"Nonalcoholic Fatty Liver Disease in Children","volume":"38","author":"Mann","year":"2018","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.ecl.2023.02.001_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"Vos","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ecl.2023.02.001_bib24","author":"Ovchinsky"},{"issue":"5","key":"10.1016\/j.ecl.2023.02.001_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.ecl.2023.02.001_bib26","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ecl.2023.02.001_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101755","article-title":"Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease","volume":"46","author":"Chen","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.ecl.2023.02.001_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MPG.0b013e31821b4b61","article-title":"Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD","volume":"53","author":"Shannon","year":"2011","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.ecl.2023.02.001_bib29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","article-title":"Diagnosis of nonalcoholic fatty liver disease in children and adolescents: Position paper of the ESPGHAN hepatology committee","volume":"54","author":"Vajro","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.ecl.2023.02.001_bib30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2014.11.027","article-title":"Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique","volume":"13","author":"Lin","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ecl.2023.02.001_bib31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7863\/ultra.33.5.853","article-title":"Transient elastography and sonography for prediction of liver fibrosis in infants with biliary atresia","volume":"33","author":"Shin","year":"2014","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.ecl.2023.02.001_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpeds.2016.03.021","article-title":"Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients","volume":"173","author":"Desai","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.ecl.2023.02.001_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpeds.2013.07.050","article-title":"Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease","volume":"164","author":"Xanthakos","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ecl.2023.02.001_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.663351","article-title":"Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy","volume":"12","author":"Friesen","year":"2021","journal-title":"Front Endocrinol"},{"issue":"15","key":"10.1016\/j.ecl.2023.02.001_bib35","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1203388","article-title":"A\u00a0Randomized Trial of Sugar-Sweetened Beverages and Adolescent Body Weight","volume":"367","author":"Ebbeling","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.ecl.2023.02.001_bib36","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa1203034","article-title":"A\u00a0Trial of Sugar-free or Sugar-Sweetened Beverages and Body Weight in Children","volume":"367","author":"de Ruyter","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ecl.2023.02.001_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/nu11091987","article-title":"Dietary fructose and the metabolic syndrome","volume":"11","author":"Taskinen","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ecl.2023.02.001_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean Diet Improves Hepatic Steatosis and Insulin Sensitivity in Individuals with Non-Alcoholic Fatty Liver Disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"16","key":"10.1016\/j.ecl.2023.02.001_bib39","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ecl.2023.02.001_bib40","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/17512433.2020.1829468","article-title":"The pharmacological treatment of nonalcoholic fatty liver disease in children","volume":"13","author":"Crudele","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"17","key":"10.1016\/j.ecl.2023.02.001_bib41","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A\u00a0Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2023.02.001_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.ecl.2023.02.001_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving Role for Pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin Transl Sci"},{"issue":"10215","key":"10.1016\/j.ecl.2023.02.001_bib44","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ecl.2023.02.001_bib45","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","article-title":"Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial","volume":"27","author":"Ratziu","year":"2021","journal-title":"Nat Med"},{"issue":"22","key":"10.1016\/j.ecl.2023.02.001_bib46","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A\u00a0randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852923000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852923000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:48:15Z","timestamp":1760176095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852923000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0889852923000099"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2023.02.001","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}